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Background: Dietary phosphorus (P) intake in Western countries is 2- to 3-fold higher than recommended, and
phosphate is widely used as a food additive in eg. cola beverages and processed meat products. Elevated serum
phosphate concentrations have been associated with cardiovascular disease (CVD) risk factors and CVD itself in
several studies in patients with renal dysfunction and in a few studies in the general population. Carotid
intima-media thickness (IMT) is a CVD risk factor, thus the aim of the study was to determine if an association
between dietary P, especially food additive phosphate (FAP), intake, and IMT exists.
Methods: Associations among total phosphorus (TP) and FAP intake and carotid IMT were investigated in a
cross-sectional study of 37- to 47-year-old females (n = 370) and males (n = 176) in Finland. Associations among TP
intake, FAP intake, and IMT were tested by analysis of covariance (ANCOVA) in quintiles (TP) and sextiles (FAP) using
sex, age, low-density/high-density lipoprotein cholesterol ratio, smoking status, and IMT sonographer as covariates.
Results: No significant associations were present between TP or FAP intake and IMT (p > 0.05, ANCOVA), but in
between-group comparisons some differences were found indicating higher IMT among subjects with higher P
intake. When testing for a significant linear trend with contrast analysis, a positive trend was observed between
energy-adjusted TP intake and IMT among all subjects (p = 0.039), and among females a tendency for a trend
existed (p = 0.067). Among all subjects, a significant positive linear trend was also present between FAP intake and
IMT (p = 0.022); this trend was also seen in females (p = 0.045). In males, no significant associations or trends were
noted between TP or FAP intake and IMT (p > 0.05).
Conclusions: Our results indicate that a significant linear trend exists between energy-adjusted TP intake and FAP
intake, and IMT among all subjects. Based on these results, high dietary P intake should be further investigated due
to its potential association with adverse cardiovascular health effects in the general population.
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Dietary phosphorus (P) intake in Western countries is 2- to
3-fold higher [1-3] than the nutritional recommendations
(600–700 mg/d) [4,5] due to abundant consumption of
dairy and meat products. P intake has also increased as a
consequence of the expanding use of phosphates as addi-
tives in the food industry. In the United States, P intake
from additives is estimated to have doubled to 1000 mg/d
from 1990; 50% of P intake in Western countries comes
from the additives as “hidden phosphorus” [6]. P additives
also seem to be more absorbable in the intestine than
natural P [7,8].
The detrimental effects of dietary P and elevated
serum phosphate (S-Pi) concentrations on cardiovascu-
lar disease (CVD) were first perceived in renal patients
[9]. In the last decade, results on S-Pi were found also in
studies of subjects with normal renal function; associa-
tions between S-Pi, mortality, and CVD emerged [10],
and elevated S-Pi concentrations even in young persons
were associated with atherosclerosis risk [11] and higher
carotid intima-media thickness (IMT) [12], which is a
CVD risk factor. Only limited data on the direct effects
of a high-P diet on cardiovascular health are available. In
animals, high-P diet has increased vascular calcification
[13] and in humans has impaired endothelial function of
the vascular system been reported [14]. However, accor-
ding to a recent opinion in European Heart Journal, not
only S-Pi but also dietary P has been proposed to be
considered as a CVD risk factor [15].
No studies focusing on associations between dietary P
intake and IMT in the normal population have been
carried out. Here, we hypothesize that high P intake,
especially food additive phosphate (FAP) intake, is asso-
ciated with higher IMT. We investigated by a cross-
sectional design in a middle-aged Finnish population
the associations among total dietary P and FAP intake
and IMT to determine whether high dietary P intake
should be considered a CVD risk factor in a general
population.
Materials and methods
Study subjects and study design
A randomly collected sample of 1920 subjects aged 37–
47 years (50% males, 50% females) and living in the
Helsinki area, was derived from the Population Register
Centre in Finland. Subjects were contacted by mail in
November 2009 (1st sampling) and February 2010 (2nd
sampling) and invited to participate in the study. All
subjects gave their informed consent to the procedures,
which were in accord with the Helsinki Declaration. The
study protocol was approved by Helsinki Uusimaa
Hospital District Ethics Committees. The study protocol
and sampling are illustrated in Figure 1. The initial
exclusion criterion was pregnancy.Subjects visited the research unit two times during
spring 2010: on the first visit (January or March), fasting
blood samples and spot urine samples were collected and
subjects were advised to fill in the study form, which in-
cluded food records, food frequency questionnaires (FFQ)
concerning phosphorus, calcium, and vitamin D intake,
and a background questionnaire. Before the second visit,
subjects were advised to abstain from caffeine-containing
products and smoking for four hours. During this visit
common carotid IMT was scanned by ultrasonography,
blood pressure was measured by an automatic device,
volumetric bone mineral density and bone geometry were
assessed from the tibia and radius by peripheral quantita-
tive computed tomography (results not shown), and sub-
jects’ height and weight were measured. All forms were
checked by the researchers, and additional information
was requested if needed.
Totally 678 persons participated in the first visit to the
research unit either in January or March 2010 and 653 of
them in the second visit during spring 2010 (interruption
for unknown reasons, n = 25). IMT and food record data
were successfully collected from 627 persons. Of them,
postmenopausal females (n = 41, data collected by a ques-
tionnaire) were excluded from the analyses, and persons
with moderate renal dysfunction (estimated glomerular
filtration rate, eGFR < 60 ml/min) as well (n = 21) due to
potentially altered mineral metabolism. Additionally, 19
persons were excluded because they did not complete the
study due to lack of background data or due to non-
fasting blood samples. The final analyses included 546
subjects (370 females, 176 males) for whom full nutrition,
IMT, background, and biomarker data were available
(Figure 1). No significant (p > 0.05) differences were
present in age, sex, IMT, or total phosphorus (TP) intake
between excluded subjects (n = 81) and the included ones.
Some differences did, however, emerge in body mass
index (BMI) (p < 0.001) and pulse pressure (p = 0.018);
included subjects were heavier and had higher pulse pres-
sure than the excluded ones.
IMT and blood pressure measurements
Common carotid artery IMT was measured by a semi-
automatic measurement program using high-resolution
ultrasonography (Esaote MyLab30Gold, Firenze, Italy).
IMT was measured from a 1-cm sample from the bifur-
cation (bulb) with an 8- or 10-mHz linear array transducer
by three experienced sonographers. The software mea-
sured the far wall thickness bilaterally for the 1-cm
segment. The measurement was carried out on the left
and right carotid in duplicate with the subject in a supine
position [16]. The mean intima-media complex thickness
was automatically calculated in μm in diastolic phase
scans. The averages of these four measurements were used
in the analyses. Repeatability of the measurements was
Figure 1 Sampling and protocol of the study. IMT = intima-media thickness, eGFR = estimated glomerular filtration rate, FFQ = food frequency
questionnaire, F = female, M =male.
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the first IMT scanning. In addition, IMT of 15 participants
was measured by two sonographers. The coefficient of
variation between the measurements obtained by the same
sonographer (intra CV%) was 6.6 and between measure-
ments obtained by different sonographers (inter CV%) 9.2.
Vascular calcification was not assessed in this study. The
systolic and diastolic blood pressures were measured after
the IMT measurement in supine position in duplicate by
an automatic device (Omron MIT Elite Digital Automatic
Blood Pressure Monitor, OMRON Healthcare Europe B.
V., Hoofddorp, the Netherlands), and the second result
was used in the analyses. Pulse pressure was calculated as
systolic – diastolic.
Biomarkers
Twelve-hour fasting blood samples were collected between
7:30 am and 9:15 am. Serum / plasma was extracted from
blood by centrifugation (except whole-blood samples) and
stored immediately after sampling at −20°C to −70°C until
analysis. Serum total cholesterol, high-density lipoprotein
cholesterol (HDL-C), low-density lipoprotein cholesterol
(LDL-C), triglycerides, creatinine, glucose, high-sensitivityC-reactive protein, calcium (Ca) and phosphate (Pi)
concentrations, and glycosylated hemoglobin (HbA1c%)
concentrations from whole-blood samples were analyzed
by a photometric method using a Konelab20 automatic
analyzer (Thermo Clinical Labsystems, Espoo, Finland).
Inter and intra CV%s were <4.6 for the above-mentioned
analyses. Serum 25-hydroxy vitamin D (S-25(OH)D) con-
centrations were analyzed by using an IDS enzyme im-
munoassay kit (Immunodiagnostics Systems Ltd., Boldon,
UK). Inter and intra CV%s were 2.7 and 3.2, respectively.
Serum intact parathyroid hormone (S-iPTH) concentra-
tions were analyzed by immunoluminescence-based
method by Immulite1000 (Siemens Healthcare Diagnos-
tics, Malvern, PA, USA). Inter and intra CV%s were 8.0
and <5.5, respectively. Serum insulin concentrations were
also analyzed by Immulite1000, the inter and intra CV%s
being <4.9 and <6.2, respectively. Plasma carboxy-terminal
fibroblast growth factor (P-FGF-23) concentrations were
evaluated by using an Immutopics enzyme immunoassay
kit (Immutopics Inc., San Clemente, CA, USA), and inter
and intra CV%s were <5.5 and <7.7, respectively. LDL-C
/HDL-C ratio was calculated as LDL-C/HDL-C. eGFR was
determined by using the Cockroft-Gault formula [17].
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Habitual dietary intake data of subjects were collected by
3-day food records, which included two weekdays and one
weekend day. The subjects were instructed to maintain
their normal food habits during the recording period and
to record all foods, beverages, and dietary supplements
immediately after consumption. Nutrient intake was cal-
culated using a computer-based program (Diet 32 version
1.4.6.2, Aivo2000, Turku, Finland) based on the Finnish
food composition database Fineli® (Institution of Health
and Welfare, Helsinki, Finland). Approximately 400 new
recipes were added to the program to ensure accurate
calculation of nutrient intake. Vitamin D and Ca supple-
mentation was taken into account in the calculations.
FAP intake calculations were based on one-month food
use frequency data, which were collected by a validated
FFQ concerning P intake, ranging from “less than one por-
tion per month” to daily portions [18]. The FFQ included
P sources in different food groups, distinguishing FAP-
containing foodstuffs from natural P-containing foodstuffs,
and also including P sources not consumed every day. For
FAP intake calculations, we chose products known to
contain FAP and separated these into food groups meeting
the EU regulation for maximum FAP content (meat pro-
ducts like marinated meat, sausages, and cold cuts; cola
beverages; processed cheeses, Table 1). FAP intake from
different sources was calculated from the portions of FAP-
containing foodstuffs as grams and recorded on the FFQ,
using the maximum amount of FAP allowed in the food-
stuff according to European Union regulations (meatTable 1 Food additive phosphate (FAP) -containing
products included in FAP intake calculations
FAP-containing product Portion size
Processed meat products
Processed, marinated chicken, turkey,
beef,
1 steak (130 g)
pork, or other meat
Liver pâté and liver sausage, regular
and light
1 tablespoon (15 g)
Sausages / frankfurters, regular and
light
10 cm slice of big sausage, 3
frankfurters
or 1 barbeque sausage (100 g)
Meat cold cuts, regular and light 1 slice (15 g)
Sausage-style cold cuts, regular and
light
1 slice (15 g)
Processed cheeses
With different fat contents: 1 tablespoon or
>24%, 20-24%, 9-19%, and 9% one individually packed slice
(15 g)
Cola beverages
Regular and light One glass (200 mL)products 5 g/kg; cola beverages 700 mg/L; processed
cheeses 20 g/kg [19]). We used only these products be-
cause in them the amount of added FAP is regulated,
unlike for example starch-based FAPs. Cookies were ex-
cluded from the calculations because some do not contain
FAPs. We divided subjects into tertiles concerning each
FAP group (meat products, cola beverages, processed
cheeses) intake, with score 0 indicating the lowest intake
tertile, score 1 the middle tertile, and score 2 the highest
tertile. We summed the scores from different FAP sources
for each subject; thus, each person was given a score from
zero to six. No-one received a score of 0, thus, we used the
scoring 1–6 and divided the subjects into six groups; the
final group sizes were sufficient for analysis of covariance
(ANCOVA). Due to the method, the sizes of FAP intake
groups were not equal. We used this calculation method
because the exact FAP content in foodstuffs is unknown.
When analyzing the sexes separately, the calculations were
done in sex-specific groups.
Background data were collected by a questionnaire
covering disease history and lifestyle factors such as smo-
king status, physical activity, and menopause. BMI was
calculated as weight (kg) / height (m)2.
Statistical analysis
Statistical analysis was performed using PASW Statistics
version 18.0.2 (IBM, Armonk, NY, USA). The normality
and homogeneity of the data were verified. Equality of
the variances in quintiles and FAP groups was assessed
by Levene’s test.
Correlations among IMT, TP, energy-adjusted TP (eTP),
and FAP intake and potential confounding factors were
assessed by Pearson correlation coefficients (data not
shown). We chose covariates depending on their corre-
lation with IMT and P intake and their contextual signifi-
cance. Highly intercorrelated (r > 0.2) confounding factors
were not used in the same models. Due to the high corre-
lation between Ca and P intake, Ca was excluded from the
covariates. BMI correlated with IMT, TP intake, and al-
most all potential covariates, and thus, BMI was also ex-
cluded from the covariates. We used serum LDL-C/HDL-C
ratio because it predicts IMT progression better than
HDL-C or LDL-C alone [20]. IMT scanning results of
one sonographer differed significantly from the others,
thus, sonographer class was coded as a dummy variable
(0 for nondiffering sonographer, 1 for differing sonogra-
pher) and used as a random factor in ANCOVA. Smoking
status was also coded as dummy (0 for never-smoker, 1
for former or current smoker). The final covariates were
sex (when analyzing all subjects), age, smoking status,
LDL-C/HDL-C ratio, and IMT sonographer as a random
factor. We also included pulse pressure in some models,
but this did not strengthen the results (data not shown). P
value less than 0.05 was considered statistically significant.
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concerning potential confounding factors were analyzed
by analysis of variance (ANOVA, unadjusted for cova-
riates). We used ANCOVA to analyze differences in
IMT between TP / eTP / FAP intake quantiles; we were
especially interested in determining whether high TP /
eTP / FAP intake is associated with higher IMT. Tests
for statistically significant linear trends in associations
between P variable intakes and IMT were performed by
contrast analysis.
Results
Characteristics of subjects potentially associated with
phosphorus intake
Background and biomarker data of study subjects are
shown in Tables 2 and 3, respectively. Below we report
the differences (ANOVA, unadjusted for covariates) in
the background and biomarker factors described in
Tables 2 and 3 in TP and eTP quintiles, and in FAP
groups. We report only significant differences between
the quantiles for all subjects and also pay attention to
S-Pi, P-FGF-23, S-iPTH, and S-25(OH)D concentra-
tions, as well as to Ca:P intake ratios. Results for fe-
males were somewhat similar to all subjects, and males
had only a few significant differences (data not shown).
Total phosphorus intake
In TP intake quintiles, the sexes were not distributed
equally; the number of females was smaller in higher
TP intake quintiles (p < 0.001). LDL-C/HDL-C ratioTable 2 Background data of study subjects
Variable All (n = 54
Intima-media thickness (μm) 552 ± 69
Body mass index (kg/m2) 26.8 ± 4.
Age (years) 41.9 ± 2.
Sex (% females) 67 ± 47
Current or former smoker (%) 48 ± 50
Systolic blood pressure (mmHg) 125 ± 14
Diastolic blood pressure (mmHg) 77 ± 11
Pulse pressure (mmHg) 48 ± 6
All physical activity (mins/week) 479 ± 38
Energy intake (kJ/day) 8413 ± 19
Fat intake (g/day) 80 ± 26
Saturated fat intake (g/day) 29 ± 11
Phosphorus intake (mg/day) 1617 ± 42
Calcium intake (mg/day) * 1199 ± 45
Vitamin D intake (ug/day) * 9.1 ± 8.6
Energy-adjusted phosphorus intake (mg/MJ/day) 194 ± 36
FAP intake score 3.2 ± 1.4
Values are presented as mean ± SD. * supplements included; FAP Food additive pho(p = 0.019), eGFR (p = 0.001), HbA1c% (p = 0.007),
energy intake (p < 0.001), total and saturated fat in-
take (p < 0.001 for both), and Ca and vitamin D
intake (p < 0.001) were higher with higher TP intake.
No significant differences in S-Pi (p = 0.739), P-FGF-23
(p = 0.511), S-iPTH (p = 0.173), or S-25(OH)D (p =
0.073) concentrations emerged between TP quintiles.
Ca:P ratios between quintiles differed almost signifi-
cantly with a tendency to higher Ca:P ratio with higher
TP intake (p = 0.059).
Energy-adjusted total phosphorus intake
In eTP intake quintiles, energy intake (p < 0.001) and
total and saturated fat intake (p < 0.001 for both) were
lower when eTP intake was higher. Ca (p < 0.001),
vitamin D (p = 0.004), and TP (p < 0.001) intakes were
positively related to eTP intake. S-Pi and P-FGF-23 con-
centrations did not differ significantly across quintiles
(p = 0.731 and p = 0.187, respectively). S-iPTH concen-
trations were lower (p = 0.045) and S-25(OH)D concen-
trations higher (p = 0.004) with higher eTP intake. Ca:P
ratios were lower with lower eTP intake (p = 0.018).
Food additive phosphate intake
In FAP intake groups, the sexes were not distributed
equally; the proportion of females was smaller with
higher FAP intake scores (p = 0.003). Differences in BMI
were also perceived (p < 0.001); BMI was higher in the
highest intake groups. We found differences in pulse
pressure (p = 0.019), rising with higher FAP intake.6) Females (n = 370) Males (n = 176)
544 ± 70 567 ± 66
9 26.6 ± 5.2 27.2 ± 3.9
8 41.9 ± 2.7 42.1 ± 3.0
100 -
45 ± 50 55 ± 50
122 ± 14 129 ± 13
76 ± 11 80 ± 11
47 ± 6 50 ± 6
0 515 ± 397 406 ± 332
94 7944 ± 1807 9398 ± 2014
76 ± 26 88 ± 25
28 ± 11 32 ± 11
8 1532 ± 378 1795 ± 469
3 1195 ±435 1207 ± 489
9.4 ± 9.3 8.4 ± 6.8
195 ± 37 192 ± 34
3.1 ± 1.3 3.6 ± 1.4
sphate.
Table 3 Biomarker data of study subjects
Variable All (n = 546) Females (n = 370) Males (n = 176)
S-Pi (mmol/L) 1.09 ± 0.15 1.10 ± 0.15 1.06 ± 0.16
S-Ca (mmol/L) a 2.09 ± 0.07 2.09 ± 0.07 2.10 ± 0.07
P-FGF-23, C-terminal (RU/mL) 78.5 ± 84.7 85.1 ± 101.7 64.9 ± 20.1
S-PTH (pg/mL) 55.0 ± 25.2 56.9 ± 26.0 51.0 ± 23.0
S-25(OH)D (nmol/L) 55.4 ± 19.5 56.4 ± 20.0 53.4 ± 18.3
S-total cholesterol (mmol/L) 5.45 ± 0.90 5.29 ± 0.84 5.77 ± 0.93
S-HDL (mmol/L) 1.51 ± 0.40 1.61 ± 0.39 1.33 ± 0.37
S-LDL (mmol/L) 2.94 ± 0.79 2.75 ± 0.72 3.34 ± 0.79
LDL-HDL ratio 2.13 ± 0.94 1.85 ± 0.77 2.71 ± 0.98
S-triglycerides (mmol/L) 1.30 ± 0.73 1.14 ± 0.61 1.62 ± 0.86
eGFR (mL/min) 91.5 ± 20.9 85.6 ± 19.5 103.5 ± 18.6
S-HS-CRP (mg/L) 2.07 ± 4.47 2.13 ± 4.22 1.93 ± 4.97
S-Glucose (mmol/L) 5.08 ± 0.60 5.00 ± 0.48 5.24 ± 0.78
HbA1c% 5.06 ± 0.26 5.04 ± 0.24 5.11 ± 0.28
Values are presented as mean ± SD.
Abbreviation: S Serum, P Plasma, Pi Phosphate Ca Calcium FGF-23 Fibroblast growth factor 23, PTH Parathyroid hormone, 25(OH)D 25-hydroxy vitamin D, HDL
High-density lipoprotein, LDL Low-density lipoprotein, eGFR Estimated glomerular filtration rate, HS-CRP High-sensitivity C-reactive protein, HbA1c% Glycosylated
hemoglobin (% of total hemoglobin) a adjusted to albumin.
Figure 2 Mean carotid intima-media thickness (IMT) with upper
limit of 95% confidence interval in TOTAL PHOSPHORUS (TP)
intake quintiles for ALL SUBJECTS (WHITE SCALE;
1st: 0–1272 mg/d, n = 109; 2nd: 1273–1462 mg/d, n = 109;
3rd: 1463–1665 mg/d, n = 109; 4th: 1666–1962 mg/d, n = 109;
5th: 1963–3205 mg/d, n = 110; p for all 0.233, ANCOVA), for
FEMALES (GRAY SCALE; 1st: 0–1232.7 mg/d, n = 74; 2nd: 1233–
1390 mg/d, n = 74; 3rd: 1391–1563 mg/d, n = 75; 4th: 1564–
1795 mg/d, n = 73; 5th: 1796–2800 mg/d, n = 74; p for all 0.293,
ANCOVA) and for MALES (BLACK SCALE; 1st: 0–1443 mg/d, n =
34; 2nd: 1444–1610 mg/d, n = 35; 3rd: 1611–1850 mg/d, n = 35;
4th: 1851–2163.9 mg/d, n = 36; 5th: 2164.0-3205 mg/d, n = 35;
p for all 0.719, ANCOVA). The data are adjusted for sex (when
analyzing all subjects), age, LDL-HDL cholesterol ratio, smoking
status, and IMT sonographer class. Statistically significant differences
from the highest TP intake quintile (ANCOVA) are shown with an
asterisk (* p < 0.05) (between all other groups p > 0.05).
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(p = 0.003), eGFR (p < 0.001), HbA1c% (p = 0.017), TP
(p = 0.015), and energy (p = 0.010) intake were also
associated with higher FAP intake. No significant dif-
ferences emerged in P-FGF-23 (p = 0.499), S-iPTH (p =
0.313), S-25(OH)D concentrations (p = 0.418), or in Ca:P
ratios (p = 0.266), but S-Pi concentrations were negatively
associated with FAP intake (p = 0.006).
Associations between phosphorus intake variables and
IMT
We report only the results of all subjects and females in
the text because among males no significant associa-
tions emerged between TP / eTP / FAP intake and IMT
(p > 0.05). Results of males are shown in Figures 2, 3
and 4, where relatively large confidence intervals in
IMT can be seen. The data were adjusted for sex (when
analyzing all subjects), age, LDL-C/HDL-C ratio, smo-
king status, and IMT sonographer class.
Total phosphorus intake
Results of ANCOVA are shown in Figure 2. No significant
association was present between TP intake and IMT (for
all p = 0.233, for females p = 0.293, ANCOVA). However,
in between-group comparison in females the 1st and 5th
intake quintiles differed significantly (p = 0.035); IMT was
higher with higher TP intake. No significant linear trend
in associations between TP intake and IMT was observed
among all subjects (p = 0.136, contrast analysis), but
among females an almost significant positive linear trend
was present (p = 0.072, contrast analysis).
Figure 3 Mean carotid intima-media thickness (IMT) with upper
limit of 95% confidence interval in ENERGY-ADJUSTED
PHOSPHORUS (eTP) intake quintiles for ALL SUBJECTS (WHITE
SCALE; 1st: 0–162.1 mg/MJ/d, n = 109; 2nd: 162.2-182.8 mg/MJ/
d, n = 109; 3rd: 182.9-200.85 mg/MJ/d, n = 109; 4th: 200.86-
222.1 mg/MJ/d, n = 109; 5th: 222.2-320 mg/MJ/d, n = 110; p for
all 0.289, ANCOVA), for FEMALES (GRAY SCALE; 1st: 0–
164.5 mg/MJ/d, n = 74; 2nd: 164.6-183.0 mg/MJ/d, n = 74; 3rd:
183.1-203.0 mg/MJ/d, n = 75; 4th: 203.1-224.0 mg/MJ/d, n = 73;
5th: 224.1-310 mg/MJ/d, n = 74; p for all 0.231, ANCOVA), and
for MALES (BLACK SCALE; 1st: 0–160 mg/MJ/d, n = 35; 2nd:
161–182 mg/MJ/d, n = 35; 3rd: 183–198 mg/MJ/d, n = 35; 4th:
199–218.0 mg/MJ/d n = 36; 5th: 218.1-320 mg/MJ/d, n = 35; p
for all 0.432, ANCOVA). The data are adjusted for sex (when
analyzing all subjects), age, LDL-HDL cholesterol ratio, smoking
status, and IMT sonographer class. Significant differences from the
highest eTP intake quintile (ANCOVA) / statistically significant trends
(contrast analysis) between eTP intake and IMT are indicated with
asterisks (*p < 0.05) (between all other groups p > 0.05).
Figure 4 Mean carotid intima-media thickness (IMT) with upper
limit of 95% confidence interval in FOOD ADDITIVE
PHOSPHATE (FAP) intake groups for ALL SUBJECTS (WHITE
SCALE; 1: n = 66; 2: n = 111, 3: n = 151; 4: n = 109, 5: n = 85; 6: n
= 29; p for all 0.097, ANCOVA), for FEMALES (GRAY SCALE; 1: n
= 45; 2: n = 77; 3: n = 101; 4: n = 73; 5: n = 55; 6: n = 20; p for all
0.267, ANCOVA), and for MALES (BLACK SCALE; 1: n = 16; 2: n =
39; 3: n = 54; 4: n = 28; 5: n = 33; 6: n = 10; p for all 0.372,
ANCOVA). The data are adjusted for sex (when analyzing all
subjects), age, LDL-HDL cholesterol ratio, smoking status, and IMT
sonographer class. Statistically significant differences from the
highest FAP intake group (ANCOVA) / statistically significant trends
(contrast analysis) between FAP intake and IMT are indicated with
asterisks (*p < .05, **p < 0.01) (between all other groups p > 0.05).
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Results of ANCOVA are shown in Figure 3. No signifi-
cant association existed between eTP intake and IMT
(for all p = 0.289, for females p = 0.231, ANCOVA).
However, in between-group comparison among all sub-
jects the 1st and 5th intake quintiles differed almost sig-
nificantly (p = 0.064). Among females, the 1st quintile
differed almost significantly (p = 0.065) and the 2nd
quintile differed significantly (p = 0.034) from the 5th
quintile in IMT; IMT was higher with higher eTP intake.
Furthermore, a significant positive linear trend occurred
between eTP and IMT among all subjects (p = 0.039,
contrast analysis), and among females an almost signifi-
cant positive linear trend (p = 0.067, contrast analysis).
Food additive phosphate intake
Results of ANCOVA are shown in Figure 4. The popula-
tion was divided into six groups based on FAP intake
scores, as described in the methods section. Between
FAP intake and IMT no significant association was ob-
served (for all p = 0.097, for females p = 0.267,
ANCOVA). Nevertheless, in between-group analysis
among all subjects, IMT was higher with higher FAPintake while the 6th intake group differed significantly in
IMT from almost all other groups (1st p = 0.009, 2nd p =
0.032, 3rd p = 0.052, 4th p = 0.006, 5th p = 0.038); this was
also the case among females (1st p = 0.037, 2nd p = 0.045,
3rd p = 0.086, 4th p = 0.019, 5th p = 0.113). In addition, a
significant positive linear trend existed between FAP in-
take and IMT among all subjects (p = 0.022, contrast ana-
lysis) and among females (p = 0.045, contrast analysis).
Discussion
Our study demonstrated that dietary phosphorus should
be taken into account as a potential cardiovascular risk
factor not only in renal patients, but also in the general
population. We found positive linear trends in asso-
ciations among energy-adjusted dietary P intake and FAP
intake, and IMT. Moreover, IMT of females was signifi-
cantly higher in the highest TP intake quintile compared
to the lowest intake quintile. The results strengthen the
hypothesis that not only elevated serum phosphate con-
centrations, but also higher dietary P intake may be asso-
ciated with higher IMT in a normal, healthy population.
Data on health effects of high P intake on the normal
population are scarce; most of the studies carried out on P
intake have focused on bone health [21-24].
We wanted to address our research question sepa-
rately for TP intake and FAP intake because FAP is more
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the proportion of FAP in TP is unknown and FAP
amounts in foodstuffs between manufacturers vary greatly.
We also paid attention to TP intake and, when adjusted
for energy intake, describes the P density of the diet, ex-
cluding energy intake as a potential confounding factor.
While marked variation in TP intake can be seen between
the smallest intake quintile (ca. 1100 mg/d) and the
highest one (ca. 2300 mg/d), on average all subjects
exceeded recommended intakes [4,5]. However, it should
be noted that persons in Finland usually have a high
dietary Ca intake [2], as also our study subjects had (mean
intake about 1200 mg/d).
IMT, the main outcome of the study, is a marker of
pre-clinical atherosclerosis and is associated with such
traditional CVD risk factors as smoking, diastolic blood
pressure, age, serum glucose, and LDL-C concentration
[25,26]. Additionally, male sex and black race are asso-
ciated with higher IMT [25]. Already in younger popula-
tions changes in carotid IMT can be seen [27]. FGF-23, a
bone-derived hormone-like phosphatonin, has been
speculated to participate in the effects of P in CVD, but
the mechanisms are unknown [28]. High FGF-23 con-
centrations have been associated with CVD risk factors
[29] and CVD itself [30] but results of many studies are
discordant [31], and to our knowledge, no studies have
focused on FGF-23 and IMT in the general population.
Dietary P load has been shown to increase FGF-23 con-
centration in serum acutely [32], however, in our study
P-FGF-23 concentration was not associated with dietary
P intake which may be due to the cross-sectional design
and not adjusting for potential covariates.
The regulation of Pi plays a role in vascular calcification.
Smooth vascular muscle cells differentiate to osteoblast/
chondrocyte-like cells under high Pi concentrations which
induce calcification [33,34]. Ruan et al. [12] reported that
high S-Pi was associated with higher IMT, and Park et al.
[35] found that lower S-Pi was associated with less coro-
nary calcification. However, in our study FAP intake was
associated with IMT, but IMT was inversely associated
with S-Pi concentrations. It should be noted that analyses
on S-Pi were not adjusted for potential covariates, and, in
addition, our blood samples were collected when the S-Pi
is at its lowest concentration, which may explain the in-
verse association between FAP intake and S-Pi. Notable is
that in the Health Professionals Follow-Up Study, plasma
phosphate concentration was not associated with the
development of coronary heart disease among males [36].
However, we have no information about the sample col-
lection time of the other studies, and the contradictories
may be explained by this. In the studies of Mataix et al.
[37] and de Boer et al. [38], dietary P intake correlated
only weakly with S-Pi and Mataix et al. [37] concluded
that because S-Pi is tightly controlled, dietary P does notaffect S-Pi very efficiently. The cross-sectionality of
these studies and our study may affect the results be-
cause clinical studies carried out at our unit indicate an
acute dose–response effect of dietary P on S-Pi concen-
tration [8,21,22].
One limitation of the study is its cross-sectional design,
which precludes an evaluation of causality. However, it is
also difficult to know if the dietary intake methods in the
current study are indicative of usual diet. Selection bias
may also exist; our study subjects may be healthier than
the normal population because they were interested in
participating in this kind of study. There may be some dif-
ferences between the sexes in adaptation to P; here the
association was affected by sex. Women being more vul-
nerable to P, especially through Ca and PTH metabolism
[39], may explain not finding differences among males.
Nevertheless, the distribution of sexes in our study was
not equal; the number of females was twice the number of
males, and the sizes of FAP groups differed widely, with
the smallest group sizes having the highest FAP intake
scores. In the case of males, the size was only ten persons,
which may also cause the lack of power in the analyses.
Strengths of our study are that many biomarkers were
analyzed and extensive background data were available. In
large studies where the main focus was not nutritional,
food intake data may have been collected less accurately
than in our study. The way that FAP intake is calculated
may be criticized, but one should realize that the informa-
tion on the exact amounts of FAP in foodstuffs is not
available.
Conclusion
Our results show significant linear trends in the associa-
tions among energy-adjusted dietary phosphorus intake,
food additive phosphorus intake and carotid intima-media
thickness in a healthy, middle-aged Caucasian population.
Based on these results, high dietary P intake should be fur-
ther investigated due to its potential association with
CVD risk factors in the general population, not only in
renal patients. Furthermore, prospective, or even better,
long-term intervention studies are required to evaluate
the possible impact of dietary P burden on risk of CVD.
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